TABLE OF CONTENTS
Volume 32, Issue 3 (August (1) 2003)
Progenitor Cell Mobilisation |
Peripheral Blood Stem Cells |
Mesenchymal Stem Cells |
Acute Leukaemia |
Hodgkin's disease |
Non-Hodgkin's Lymphoma |
Allografting |
Autografting |
Circulating Tumour Cells |
Viral Infections |
Second Malignancies |
Unrelated Donor Searches |
Case Reports |
Correspondence
Anti-Thymocyte Globulin
Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML FREE
F Bonifazi, G Bandini, D Rondelli, S Falcioni, M Stanzani, A Bontadini, P L Tazzari, M Arpinati, B Giannini, R Conte and M Baccarani
Bone Marrow Transplant 32: 237-242; doi:10.1038/sj.bmt.1704138
Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML FREE
M Schleuning, W Günther, J Tischer, G Ledderose and H-J Kolb
Bone Marrow Transplant 32: 243-250; doi:10.1038/sj.bmt.1704135
Progenitor Cell Mobilisation
High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II–IIIA breast cancer FREE
U De Giorgi, G Rosti, A Zaniboni, M Ballardini, M R Minzi, M Baioni, E Ferrari, L Zornetta and M Marangolo
Bone Marrow Transplant 32: 251-255; doi:10.1038/sj.bmt.1704125
Peripheral Blood Stem Cells
Fewer relapses and increased chronic GVHD in patients transplanted with blood stem cells: a 5-year follow-up in a single centre study FREE
D Heldal, L Brinch, G Tjønnfjord, B G Solheim, T Egeland, D Albrechtsen, G Aamodt and S A Evensen
Bone Marrow Transplant 32: 257-264; doi:10.1038/sj.bmt.1704127
Mesenchymal Stem Cells
Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells FREE
C Götherström, O Ringdén, M Westgren, C Tammik and K Le Blanc
Bone Marrow Transplant 32: 265-272; doi:10.1038/sj.bmt.1704111
Acute Leukaemia
Stem cell transplantation after salvage therapy with high-dose cytarabine and amsacrine in adults with high-risk leukaemia FREE
S Tauro, P Shankaranarayana, I C Nitu-Whalley, N Duncan, G Begum, J I O Craig, R E Marcus, C F Craddock and P Mahendra
Bone Marrow Transplant 32: 273-278; doi:10.1038/sj.bmt.1704113
Hodgkin's disease
Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen FREE
F Gutierrez-Delgado, L Holmberg, H Hooper, S Petersdorf, O Press, R Maziarz, D Maloney, T Chauncey, F Appelbaum and W Bensinger
Bone Marrow Transplant 32: 279-285; doi:10.1038/sj.bmt.1704110
Non-Hodgkin's Lymphoma
Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course FREE
C-C Chang, C Bredeson, M Juckett, B Logan and C A Keever-Taylor
Bone Marrow Transplant 32: 287-291; doi:10.1038/sj.bmt.1704130
Allografting
Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials FREE
J T Horan, J L Liesveld, I D Fernandez, G H Lyman, G L Phillips, N B Lerner and S G Fisher
Bone Marrow Transplant 32: 293-298; doi:10.1038/sj.bmt.1704112
Autografting
Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells FREE
A Reichle, M Zaiss, G Rothe, G Schmitz and R Andreesen
Bone Marrow Transplant 32: 299-305; doi:10.1038/sj.bmt.1704126
Circulating Tumour Cells
Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT) FREE
R Syme, D Stewart, M Rodriguez-Galvez, J Luider, Y Auer, J Klassen, D Morris, C Brown, J Russell and S Glück
Bone Marrow Transplant 32: 307-311; doi:10.1038/sj.bmt.1704133
Viral Infections
MxA expression in patients with viral infection after allogeneic stem cell transplantation FREE
T Yoshimasu, A Manabe, Y Ebihara, R Tanaka, J Ooi, T Iseki, N Shirafuji, T Maekawa, S Asano, N Yoshikawa and K Tsuji
Bone Marrow Transplant 32: 313-316; doi:10.1038/sj.bmt.1704128
Second Malignancies
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma FREE
R Howe, I N M Micallef, D J Inwards, S M Ansell, G W Dewald, A Dispenzieri, D A Gastineau, M A Gertz, S M Geyer, C A Hanson, M Q Lacy, A Tefferi and M R Litzow
Bone Marrow Transplant 32: 317-324; doi:10.1038/sj.bmt.1704124
Unrelated Donor Searches
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission FREE
G Dini, M Grazia Valsecchi, C Micalizzi, A Busca, A Balduzzi, W Arcese, S Cesaro, A Prete, M Rabusin, E Mazzolari, P Di Bartolomeo, N Sacchi, A Pession, G Giorgiani, E Lanino, T Lamparelli, C Favre, A Bosi, C Manzitti, S Galimberti and F Locatelli
Bone Marrow Transplant 32: 325-331; doi:10.1038/sj.bmt.1704132
Case Reports
Refractory chronic GVHD emerging after splenectomy in a marrow transplant recipient with accelerated phase CML FREE
C A Rodrigues, F A Fermino, Y Vasconcelos and J S R de Oliveira
Bone Marrow Transplant 32: 333-335; doi:10.1038/sj.bmt.1704122
Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation FREE
W Kreisel, K Potthoff, H Bertz, A Schmitt-Graeff, G Ruf, J Rasenack and J Finke
Bone Marrow Transplant 32: 337-340; doi:10.1038/sj.bmt.1704134
Correspondence
Homozygous 
-thalassemia treated with intrauterine transfusions and postnatal hematopoietic stem cell transplantation FREE
I Thornley, L Lehmann, W S Ferguson, I Davis, E N Forman and E C Guinan
Bone Marrow Transplant 32: 341-342; doi:10.1038/sj.bmt.1704129
Response to single-agent thalidomide and eligibility to undergo autotransplant for patients with multiple myeloma refractory to VAD FREE
J H Milone, V Prates, J Bordone, J Napal and C Garcia
Bone Marrow Transplant 32: 343; doi:10.1038/sj.bmt.1704140
Complete remission of a radiochemotherapy-resistant cutaneous T-cell lymphoma with allogeneic non-myeloablative stem cell transplantation FREE
R Fijnheer, C J G Sanders, M R Canninga, R A de Weger and L F Verdonck
Bone Marrow Transplant 32: 345-347; doi:10.1038/sj.bmt.1704136
